The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
| VMVAX | |
| Total Expense Ratio | 0.07 |
| Annual Report Gross Expense Ratio | 0.07 |
| Fund Existence | 14 years |
| Gain YTD | 9.780 |
| Front Load | N/A |
| Min. Initial Investment | 3000 |
| Min. Initial Investment IRA | N/A |
| Net Assets | 31.8B |
| Annual Yield % from dividends | 2.14 |
| Returns for 1 year | 1.01 |
| Returns for 3 years | 27.70 |
| Returns for 5 years | 52.92 |
| Returns for 10 years | 101.27 |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ISCV | 68.53 | 0.25 | +0.37% |
| iShares Morningstar Small-Cap Value ETF | |||
| RGEF | 30.49 | 0.10 | +0.33% |
| Rockefeller Global Equity ETF | |||
| HEFA | 41.29 | 0.02 | +0.05% |
| iShares Currency Hedged MSCI EAFE ETF | |||
| PZT | 22.49 | N/A | N/A |
| Invesco New York AMT-Free Muni Bd ETF | |||
| SPC | 21.99 | N/A | N/A |
| CrossingBridge Pre-Merger SPAC ETF | |||